Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells

被引:54
作者
Matthews, CC
Odeh, HM
Feldman, EL
机构
[1] UNIV MICHIGAN, DEPT NEUROL, ANN ARBOR, MI 48109 USA
[2] UNIV MICHIGAN, PROGRAM NEUROSCI, ANN ARBOR, MI 48109 USA
关键词
IGF-I; programmed cell death; neuroblastoma; osmoprotection; proteases;
D O I
10.1016/S0306-4522(96)00611-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A role in neuronal homeostasis is suggested by the persistent expression of the insulin-like growth factors in the adult nervous system. SH-SY5Y human neuroblastoma cells, a well-characterized in vitro model of human neurons, were used to investigate the effects of hyperosmotic stress on neurons. Neuronal DNA fragmentation was detected within 1 h and pyknotic nuclei were apparent in attached cells after 12 h of hyperosmotic stress. In parallel, flow cytometry measurements revealed a sudden increase in the rate of cells irreversibly undergoing programmed cell death after 12 h of hyperosmotic exposure. Insulin-like growth factor-I delayed the onset of a laddered DNA fragmentation pattern for 24 h and provided continuing protection against hyperosmotic exposure for 72 h. Amino acid uptake was decreased in hyperosmotic medium even in the presence of insulin-like growth factor-I; the protein synthesis inhibitor cycroheximide neither prevented the induction of programmed cell death nor interfered with the ability of insulin-like growth factor-I to act as an osmoprotectant in hyperosmotic medium. Cysteine and serine protease inhibitors each prevented DNA fragmentation under hyperosmotic conditions, suggesting that the osmoprotectant activity of insulin-like growth factor-I involves the suppression of protease activity. Collectively, these results indicate that insulin-like growth factor-I limits the death of neurons under stressful environmental conditions, suggesting that it may provide a candidate therapy in the treatment of hyperosmolar coupled neurological injury. (C) 1997 IBRO.
引用
收藏
页码:525 / 534
页数:10
相关论文
共 74 条
[1]  
ANZAI N, 1995, BLOOD, V86, P917
[2]  
BALLANYI K, 1988, RENAL PHYSIOL BIOCH, V11, P142
[3]   IGF1 GENE DISRUPTION RESULTS IN REDUCED BRAIN SIZE, CNS HYPOMYELINATION, AND LOSS OF HIPPOCAMPAL GRANULE AND STRIATAL PARVALBUMIN-CONTAINING NEURONS [J].
BECK, KD ;
POWELLBRAXTON, L ;
WIDMER, HR ;
VALVERDE, J ;
HEFTI, F .
NEURON, 1995, 14 (04) :717-730
[4]  
BONDY CA, 1993, ANN NY ACAD SCI, V692, P33
[5]  
BRUNO S, 1992, LEUKEMIA, V6, P1113
[6]   DNA CLEAVAGE IN RAT-LIVER NUCLEI ACTIVATED BY MG2+ OR CA2++MG2+ IS INHIBITED BY A VARIETY OF STRUCTURALLY UNRELATED INHIBITORS [J].
CAIN, K ;
INAYATHUSSAIN, SH ;
KOKILEVA, L ;
COHEN, GM .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1994, 72 (11-12) :631-638
[7]  
CASCIOLAROSEN LA, 1994, J BIOL CHEM, V269, P30757
[8]  
CHENG B, 1992, J NEUROSCI, V12, P1558
[9]   REEVALUATION OF THE ROLE OF DE-NOVO PROTEIN-SYNTHESIS IN RAT THYMOCYTE APOPTOSIS [J].
CHOW, SC ;
PETERS, I ;
ORRENIUS, S .
EXPERIMENTAL CELL RESEARCH, 1995, 216 (01) :149-159
[10]   CHANGES IN THE NUCLEI OF DYING NEURONS AS STUDIED WITH THYMIDINE AUTORADIOGRAPHY [J].
CLARKE, PGH ;
HORNUNG, JP .
JOURNAL OF COMPARATIVE NEUROLOGY, 1989, 283 (03) :438-449